Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/7a27b2ce-6925-41f4-8b94-e888c7172842/

HCA

HCA Healthcare, Inc.
Chart
382.19 USD
Latest Week 2026-07-24
HealthcareMedical Care FacilitiesLARGE
Snapshot 2026-07-26 · 0.9w · Fresh
0.92
OS Score
86.0%
Value
73.0%
Quality
67.0%
Momentum
#70.00000000
TV Rank
7/9
F-Score
0.792
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
11 of 23 passing
★
OS Composite
OS 0.920
↗
Trending Value
✗
◆
Quality × Value
QV 0.792
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
P/S 1.1
💎
Deep Value
P/E 12.4
◇
VC2 Cheapest
VC2 10
📐
EBITDA/EV
11.7%
◐
Veiled Value
✗
▣
Piotroski Bargains
F7
🔬
Quality Compounders
✗
📈
Consistent Earners
Yes
🌱
GARP
✗
🔄
Shareholder Yield
12.7%
💰
High Yield
✗
🚀
Momentum Leaders
12-1 18%
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
CAQ 0.65
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
86.0%ile
P/E
12.4×
P/S
1.1×
E/P
0.0895
FCF Yield
0.120
EBITDA/EV
0.117
SH Yield
0.127
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
15.00000000
/100 — 1=cheapest
VC2 (Trending Value)
10.00000000
/100
VC3 (Buyback)
12.00000000
/100
FCF yield of 12.0% is strong — the business generates significant free cash relative to price. VC2 score of 10.00000000/100 puts this in the cheapest decile of the universe — prime Trending Value territory.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
73.0%ile
ROE
-1.040
ROA
0.113
Net Margin
0.088
Op Margin
0.156
GPA
0.365
D/E
-9.68
Current
0.78
F-Score
7/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.073
Earn Growth
0.146
Stability
0.113
lower=better
Accruals
-0.071
lower=better
5yr Consist
Yes
Conservative balance sheet with D/E of -9.68.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
67.0%ile
6M Return
-18.6%
12M Return
15.1%
12-1 Mom
18.0%
Risk-Adj
0.63
Vol 252d
28.4%
Vol 60d
64.0%
↑ Expanding
Max DD 12M
-31.1%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
Near-term vol (64%) is expanding vs long-term (28%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.92
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 500 peers
Sector Value %ile
92.0%
Sector Quality %ile
80.6%
P/E z-score
-0.26
Sector Avg OS
64.8%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
IRWD Ironwood Pharmaceuticals Inc 99.0% 92.0% 90.0% 98.0%
RIGL Rigel Pharmaceuticals Inc 99.0% 92.0% 93.0% 92.0%
FBIO Fortress Biotech Inc 99.0% 98.0% 84.0% 87.0%
FBIOP Fortress Biotech Inc Pref Series A 99.0% 98.0% 84.0% 97.0%
NUTX Nutex Health Inc 99.0% 93.0% 98.0% 87.0%
CGEN Compugen 98.0% 90.0% 96.0% 83.0%
TBPH Theravance Biopharma Inc 98.0% 90.0% 99.0% 86.0%
INVA Innoviva Inc 97.0% 94.0% 94.0% 67.0%
Factor Interactions
Value + Quality Intersection
Top-tier on both cheapness (86th) and quality (73th) — the O'Shaughnessy sweet spot, historically the strongest long-term combination.
Strong Capital Return
Shareholder yield 12.7% backed by 12.0% FCF yield. Returns are well-funded.
Volatility Expanding
60-day vol (64%) significantly exceeds 252-day (28%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
A
82.6% avg (6 factors)
Quality
C
54.2% avg (8 factors)
Momentum
D
40.6% avg (4 factors)
Risk
B
69.3% avg (1 factors)
Momentum is weak, suggesting the market isn't yet buying this thesis. Patience required.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends8 snapshots
Factor Persistence8 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.920—8—
Value %ile0.860—8—
Quality %ile0.730—8—
Momentum %ile0.670—0—
F-Score7.000—8—
Confidence0.939—8—
Volatility0.284—0—
Value Lens2021-07-27 → 2026-07-26
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
12.40
Earnings Yield (E/P)
0.0895
Price / Sales
1.09
Price / Cash Flow
7.62
FCF Yield
12.0%
EBITDA / EV
11.7%
Sales Yield (1/P·S)
0.5742
Shareholder Yield
Div + net buyback / mktcap
12.7%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
-104.0%
Return on Assets
11.3%
Net Margin
8.8%
Operating Margin
15.6%
Gross Profit / Assets
Novy-Marx GPA
36.5%
Debt / Equity
-9.68
Current Ratio
0.78
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.071
MomentumPrice trend strength over different horizons
6M Return
-18.6%
12M Return
15.1%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
18.0%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
0.63
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
7.3%
Earnings Growth (YoY)
14.6%
Earnings Stability (CV)
Lower = more stable
0.113
5yr Consistent
EPS up every year for 5 years
Yes
Piotroski F-Score
7
Dividend Yield
0.8%
Buyback Yield
11.9%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
15
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
10
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
12
Trending Value Rank
1=best. Top VC2 decile by 6M momentum
70
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity